The diagnosis and treatment of primary hyperaldosteronism in Germany - Results on 555 patients from the German Conn Registry;Diagnostik und therapie des primären hyperaldosteronismus: Ergebnisse des deutschen Conn-Registers: 555 Patienten mit primärem hyperaldosteronismus

Deutsches Arzteblatt

Volumn 106, Issue 18, 2009, Pages 305-311

  Schirpenbach, Caroline ^a   Segmiller, Felix ^a   Diederich, Sven ^b   Hahner, Stefanie ^c   Lorenz, Reinhard ^a   Rump, Lars C ^d   Seufert, Jochen ^e   Quinkler, Marcus ^f   Bidlingmaier, Martin ^a   Beuschlein, Felix ^a   Endres, Stephan ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Endokrinologikum   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aldosterone; Conn's syndrome; Hyperaldosteronism; Hypertension; Hypokalemia

Indexed keywords

CALCIUM; DIURETIC AGENT;

ADRENAL GLAND; ADRENALECTOMY; ADULT; ARTICLE; DIAGNOSTIC TEST; ENDOCRINE FUNCTION; FEMALE; GERMANY; HUMAN; HYPOKALEMIA; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; REGISTER; RETROSPECTIVE STUDY; SAMPLING;

FEMALE; GERMANY; HUMANS; HYPERALDOSTERONISM; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 69049090844     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0305     Document Type: Article

References (19)

1. Fardella C, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, et al.: Primary aldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867 (Pubitemid 32269290)
2. Mulatero P, Dluhy R, Giacchetti G, Boscaro M, Veglio F, Stewart P: Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends in Endocrinology and Metabolism 2005; 16: 114-119 (Pubitemid 40432461)
3. Loh K, Koay E, Khaw M, Emmanuel S, Young W: Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-2859 (Pubitemid 32269163)
4. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A: Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007; 30: 111-117 (Pubitemid 46541784)
5. Wolf-Maier K, Cooper R, Banegas J, Giampaoli S, Hense H, Joffres M et al.: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369
6. Rocha R, Funder J: The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 2002; 970: 89-100.
7. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P et al.: Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50: 911-918 (Pubitemid 350287534)
8. Milliez P, Girerd X, Plouin P, Blacher J, Safar M, Mourad J: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248 (Pubitemid 40523144)
9. Benchetrit S, Bernheim J, Podjarny E: Normokalemic hyperaldosteronism in patients with resistant hypertension. Isr Med Assoc J 2002; 4: 17-20. (Pubitemid 34193060)
10. Diederich S, Bidlingmaier M, Quinkler M, Reincke M: Diagnostik des primären Hyperaldosteronismus. Med Klinik 2007; 102: 16-21.
11. Funder J, Carey R, Fardella C, Gomez-Sanchez C, Matero F, Stowasser M et al.: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008; 93: 3266-3281
12. Stowasser M, Gordon R, Rutherford J, Nikwan N, Daunt N, Slater G: Diagnosis and management of primary aldosteronism. JRAAS 2001; 2: 156-169
13. Schirpenbach C, Reincke M: Current knowledge and recent controversies in Conn's Syndrome. Nature Clinical Practice Endocrinology & Metabolism 2006; 3: 220-227
14. Young W, Stanson A, Thompson G, Grant C, Farley D, van Heerden J: Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-1235 (Pubitemid 39647538)
15. Vonend O, Stegbauer J, Kokulinsky P, Adams S, Liermann D, Hahn K, et al.: Vergleich von Bildgebung und seitengetrennter Nebennierenvenenblutentnahme zur Differentialdiagnose bei primärem Hyperaldosteronismus. DMW 2007; 132: 2436-2441 (Pubitemid 350204700)
16. Phillips J, Walther M, Pezzullo J, Rayford W, Choyke P, Berman A et al.: Predictive value of preoperative tests in discriminating bilateral hyperplasia from an aldosterone-producing adenoma. J Clin Endocrinol Metab 2000; 85: 4526-4533 (Pubitemid 32157628)
17. Eide I, Torjesen P, Drolsum A, Babovic A, Lilledahl N: Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 2004; 22: 2217-2226 (Pubitemid 39463817)
18. Mulatero P, Stowasser M, Loh K, Fardella C, Gordon R, Mosso L et al.: Increased diagnosis of primary aldosteronism including surgically correctable forms in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050 (Pubitemid 38368386)
19. Stowasser M, Gordon R, Gunasekera T, Cowley D, Ward G, Archibald C et al.: High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 2003; 21: 2149-2157